Back to today’s briefing

Story perspectives

Breakthrough Blood Test Offers Hope for ME/CFS Diagnosis

10/8/2025

50 8 Full Breakdown

Summary

Story summary

A blood test for ME/CFS has been developed, the first of its kind, signaling potential diagnostic advances.
The test shows 92% sensitivity and 98% specificity, suggesting more accurate diagnosis and improved patient management.
Experts urge cautious validation before clinical use, and Prof. Dmitry Pshezhetskiy emphasizes accurate diagnosis, notes potential long Covid utility, with an estimated £1,000 cost.

1 of 1

Story summary

A blood test for ME/CFS has been developed, the first of its kind, signaling potential diagnostic advances.
The test shows 92% sensitivity and 98% specificity, suggesting more accurate diagnosis and improved patient management.
Experts urge cautious validation before clinical use, and Prof. Dmitry Pshezhetskiy emphasizes accurate diagnosis, notes potential long Covid utility, with an estimated £1,000 cost.